R. G. Finch

582 total citations
19 papers, 421 citations indexed

About

R. G. Finch is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, R. G. Finch has authored 19 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Pharmacology and 5 papers in Infectious Diseases. Recurrent topics in R. G. Finch's work include Pneumonia and Respiratory Infections (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Drug-Induced Adverse Reactions (3 papers). R. G. Finch is often cited by papers focused on Pneumonia and Respiratory Infections (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Drug-Induced Adverse Reactions (3 papers). R. G. Finch collaborates with scholars based in United Kingdom, Nepal and Canada. R. G. Finch's co-authors include Brian J. Thomson, George M. Eliopoulos, Hisham Ziglam, Donald E. Low, Richard Edwards, J. Cheesbrough, Thomas Elliott, Trevor Gray, Nicola G. Jones and D. M. Jones and has published in prestigious journals such as The Lancet, Journal of Antimicrobial Chemotherapy and Journal of Clinical Pathology.

In The Last Decade

R. G. Finch

18 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. G. Finch United Kingdom 9 148 101 77 72 66 19 421
M. Micoud France 14 271 1.8× 205 2.0× 71 0.9× 78 1.1× 96 1.5× 70 739
Gian Piero Testore Italy 10 214 1.4× 190 1.9× 61 0.8× 90 1.3× 39 0.6× 18 410
Sabahattin Ocak Türkiye 15 271 1.8× 162 1.6× 69 0.9× 135 1.9× 37 0.6× 34 630
Canan Külah Türkiye 16 174 1.2× 185 1.8× 36 0.5× 112 1.6× 84 1.3× 37 582
Shahana Urooj Kazmi Pakistan 18 151 1.0× 155 1.5× 60 0.8× 121 1.7× 34 0.5× 52 642
GTA Jombo Nigeria 12 141 1.0× 60 0.6× 37 0.5× 34 0.5× 14 0.2× 58 362
Ian Eltringham United Kingdom 10 254 1.7× 252 2.5× 121 1.6× 75 1.0× 16 0.2× 14 468
Juan Pablo Caeiro Argentina 11 183 1.2× 171 1.7× 19 0.2× 30 0.4× 82 1.2× 43 463
J. Michel Israel 15 151 1.0× 100 1.0× 11 0.1× 163 2.3× 87 1.3× 57 615
V. Talwar India 12 255 1.7× 171 1.7× 12 0.2× 98 1.4× 17 0.3× 35 518

Countries citing papers authored by R. G. Finch

Since Specialization
Citations

This map shows the geographic impact of R. G. Finch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. G. Finch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. G. Finch more than expected).

Fields of papers citing papers by R. G. Finch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. G. Finch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. G. Finch. The network helps show where R. G. Finch may publish in the future.

Co-authorship network of co-authors of R. G. Finch

This figure shows the co-authorship network connecting the top 25 collaborators of R. G. Finch. A scholar is included among the top collaborators of R. G. Finch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. G. Finch. R. G. Finch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Snape, S., R. G. Finch, & Pradhib Venkatesan. (2011). Aciclovir desensitisation and rechallenge: Table 1. BMJ Case Reports. 2011. bcr1020103392–bcr1020103392. 6 indexed citations
2.
Thomson, Brian J. & R. G. Finch. (2005). Hepatitis C virus infection. Clinical Microbiology and Infection. 11(2). 86–94. 86 indexed citations
3.
Finch, R. G. & George M. Eliopoulos. (2005). Safety and efficacy of glycopeptide antibiotics. Journal of Antimicrobial Chemotherapy. 55(suppl_2). ii5–ii13. 64 indexed citations
4.
Finch, R. G.. (2003). Antibiotic and chemotherapy : anti-infective agents and their use in therapy. Churchill Livingstone eBooks. 110 indexed citations
5.
Finch, R. G. & Donald E. Low. (2002). A critical assessment of published guidelines and other decision‐support systems for the antibiotic treatment of community‐acquired respiratory tract infections. Clinical Microbiology and Infection. 8. 69–91. 23 indexed citations
6.
Ziglam, Hisham & R. G. Finch. (2001). Limitations of presently available glycopeptides in the treatment of Gram-positive infection. Clinical Microbiology and Infection. 7. 53–65. 27 indexed citations
7.
Davies, J. M., A. C. Newland, & R. G. Finch. (1997). Patient education and communication in non‐inpatient intravenous therapy – a review. European Journal Of Haematology. 59(S62). 18–23. 1 indexed citations
8.
Finch, R. G.. (1995). Meropenem : focus on clinical performance. 1 indexed citations
9.
Read, Robert C., Andrew J. Fox, Kathryn Miller, et al.. (1995). Experimental infection of human nasal mucosal explants with Neisseria meningitidis. Journal of Medical Microbiology. 42(5). 353–361. 28 indexed citations
10.
Greenwood, David & R. G. Finch. (1993). Piperacillin/tazobactam : a new ß-lactam/ß-lactamase inhibitor combination. Academic Press eBooks. 1 indexed citations
11.
Finch, R. G.. (1988). Antimicrobial agents. Current Opinion in Infectious Diseases. 1(3). 339–341.
12.
Edwards, Richard & R. G. Finch. (1986). Characterisation and antibiotic susceptibilities of Streptobacillus moniliformis. Journal of Medical Microbiology. 21(1). 39–42. 22 indexed citations
13.
Cheesbrough, J., et al.. (1985). The Management of Splenic Abscess. QJM. 57(222). 653–7. 8 indexed citations
14.
Cheesbrough, J., Thomas Elliott, & R. G. Finch. (1985). A Morphological Study of Bacterial Colonisation of Intravenous Cannulae. Journal of Medical Microbiology. 19(2). 149–157. 16 indexed citations
15.
Nolan, Niamh, et al.. (1985). PSEUDOMEMBRANOUS COLITIS. The Lancet. 326(8468). 1358–1359. 2 indexed citations
16.
Finch, R. G., et al.. (1984). Group G streptococcal septicaemia: clinical observations and laboratory studies. Journal of Infection. 9(2). 126–133. 17 indexed citations
17.
Slack, Richard, et al.. (1984). The use of injectable antibiotics in two general hospitals. Journal of Antimicrobial Chemotherapy. 14(suppl B). 77–80. 3 indexed citations
18.
Finch, R. G., et al.. (1975). A clinical, microbiological and toxicological assessment of clindamycin phosphate. Journal of Antimicrobial Chemotherapy. 1(3). 297–303. 2 indexed citations
19.
McGhie, D, J. G. P. Hutchison, & R. G. Finch. (1972). Stimulation of growth on a deficient medium of a Klebsiella aerogenes species by sulphonamide, para-amino benzoic acid, nitrofurantoin, and some other substances. Journal of Clinical Pathology. 25(11). 976–978. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026